Advances in Inflammatory Bowel Diseases

P. Rutgeerts, J-F. Colombel, S.B. Hanauer, J. Schölmerich, G.N. Tytgat (Herausgeber)

Buch | Hardcover

320 Seiten

1998
Springer (Verlag)
978-0-7923-8750-3 (ISBN)

Artikel merken

Ulcerative colitis and Crohn's disease remain a great therapeutic challenge to the medical community. In recent years knowledge about the pathogenesis of these diseases has progressed rapidly but the cause of the diseases remains completely unknown. It has become clear that dysregulation of the mucosal immune system is the basis for the chronic evolution of the diseases in a genetically susceptible population. Exciting new therapeutic approaches have been attempted in the last couple of years and cytokine and anti-cytokine treatments in particular seem very promising, especially in intractable disease.
The format of the Falk Symposium 106 on `Advances in Inflammatory Bowel Diseases', held in Brussels, Belgium, June 18-20, 1998, was somewhat innovative as each session attempted to link the new insights into pathogenetic mechanisms with new therapeutic approaches, resulting in optimal information transfer. The classic therapeutic schemes were updated with a special focus on step-wise build-up of therapy.

Preface. I. Aetiological Factors in IBD. II. Pathogenesis of IBD. III. Immunological Basis of IBD. IV. Cancer in IBD. V. Standard Therapies in IBD. VI. Surgery for IBD. VII. IBD: A Systemic Disease. Index.

Erscheint lt. Verlag	31.12.1998
Reihe/Serie	Falk Symposium ; 106
Zusatzinfo	XII, 320 p.
Verlagsort	Dordrecht
Sprache	englisch
Maße	155 x 235 mm
Themenwelt	Medizinische Fachgebiete ► Chirurgie ► Viszeralchirurgie
Themenwelt	Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie
ISBN-10	0-7923-8750-3 / 0792387503
ISBN-13	978-0-7923-8750-3 / 9780792387503
Zustand	Neuware